Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003148537 | SCV003836483 | likely pathogenic | Heterotaxy, visceral, 5, autosomal | 2022-09-09 | criteria provided, single submitter | clinical testing | |
Duke University Health System Sequencing Clinic, |
RCV003148537 | SCV003918926 | uncertain significance | Heterotaxy, visceral, 5, autosomal | 2023-04-20 | criteria provided, single submitter | research | |
Labcorp Genetics |
RCV003148537 | SCV005761631 | uncertain significance | Heterotaxy, visceral, 5, autosomal | 2024-08-15 | criteria provided, single submitter | clinical testing | This sequence change affects the initiator methionine of the NODAL mRNA. The next in-frame methionine is located at codon 44. This variant is not present in population databases (gnomAD no frequency). Disruption of the initiator codon has been observed in individual(s) with clinical features of NODAL-related conditions (PMID: 37853563). ClinVar contains an entry for this variant (Variation ID: 2442204). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |